Photo of Kohei Shitara taken from X/Twitter
Feb 15, 2024, 11:05
Kohei Shitara: Happy to report ctDNA analysis of PARADIGM at Nature Medicine
Kohei Shitara, Medical oncologist at National Cancer Center Hospital East, Japan, shared a post on X/Twitter:
“Happy to report ctDNA analysis of PARADIGM at Nature Medicine. Negative hyper selection enriched the benefit of panitumumab for colorectal cancer regardless of sidedness. Does tumor location serve as a surrogate for molecular type?”
Source: Kohei Shitara/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56